Indian Enalapril Exporters: Complete Supplier Ranking with Market Share — 261 Manufacturers (2026) — TransData Nexus

Q: Who is the largest enalapril supplier from India?

MYLAN LABORATORIES LIMITED is the largest enalapril exporter from India with a 83.8% market share and export value of $197.1M.

Q: How many enalapril suppliers are there in India?

There are 261 active enalapril exporters in India, collectively shipping $235.3M worth of enalapril across 3,403 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top enalapril suppliers from India?

The top 5 enalapril suppliers from India — MYLAN LABORATORIES LIMITED, IPCA LABORATORIES LIMITED, J B CHEMICALS AND PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LTD, WEXFORD LABORATORIES PRIVATE LIMITED — together control 91.5% of total enalapril export value from India.

Suresh Sormare

Enalapril

India Pharmaceutical Trade Intelligence

$235.3M261 Suppliers115 CountriesHS 30049071

ExportsIndia → HUNGARY83.4%India → SOUTH AFRICA4.2%

ImportsMALTA → India$658.8K UNITED STATES → India$80.8K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Enalapril Suppliers from India (2026) — 261 Exporters, $235.3M Market | TransData Nexus | TransData Nexus

Who Exports Enalapril from India — 261 Suppliers Behind a $235.3M Market

India's enalapril export market is supplied by 261 active exporters who collectively shipped $235.3M across 3,403 shipments. MYLAN LABORATORIES LIMITED leads with a 83.8% market share, followed by IPCA LABORATORIES LIMITED and J B CHEMICALS AND PHARMACEUTICALS LIMITED. The top 5 suppliers together control 91.5% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published May 2026

India's Top Enalapril Suppliers & Exporters — 261 manufacturers, $235.3M export market, top destinations and formulations — Enalapril supplier data — 261 exporters · $235.3M market · 3,403 shipmentsTransData Nexus · Indian Customs Data

Top Enalapril Exporters from India — Ranked by Export Value

MYLAN LABORATORIES LIMITED is the leading enalapril exporter from India, holding a 83.8% share of the $235.3M market across 3,403 shipments from 261 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, IPCA LABORATORIES LIMITED, J B CHEMICALS AND PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LTD, WEXFORD LABORATORIES PRIVATE LIMITED — collectively control 91.5% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (83.8%), IPCA LABORATORIES LIMITED (2.9%), J B CHEMICALS AND PHARMACEUTICALS LIMITED (2.0%), AUROBINDO PHARMA LTD (1.7%), WEXFORD LABORATORIES PRIVATE LIMITED (1.1%).

Top Enalapril Exporters from India

Ranked by export value · 261 active suppliers · Indian Customs (DGFT) data

May 2026

Top Enalapril Exporters from India — Ranked by Export Value. 261 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Enalapril — Export Intelligence Video

Visual overview of India's enalapril supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's enalapril pharmaceutical supplier landscape — $235.3M in total trade, 261 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Enalapril exporters

Certification and compliance status for top Enalapril suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
MYLAN LABORATORIES LIMITED	Warning Letter, December	Yes, as of March 202	Unknown	Not verified	FDA issued a warning letter in December 2024; WHO conducted a for-cause inspecti
MICRO LABS LIMITED	Unknown	Yes, as of February	Unknown	Not verified	WHO conducted inspections in August 2024 and February 2025 at various facilities
MEDOPHARM PRIVATE LIMITED	Unknown	Yes, as of January 2	Unknown	Not verified	WHO conducted an inspection in January 2025 at the Kayarambedu Village facility.
CADILA PHARMACEUTICALS LIMITED	Warning Letter, March 201	Yes	Unknown	Not verified	FDA issued a warning letter in March 2014 for the Ankleshwar facility.
INTAS PHARMACEUTICALS LIMITED	Warning Letter, December	Yes	Yes	Not verified	FDA issued a warning letter in December 2022 for the Sanand facility.
IPCA LABORATORIES LIMITED	Unknown	Yes	Yes	Not verified	Company has received WHO-GMP and EU GMP certifications.
AUROBINDO PHARMA LTD	Approved	Yes	Yes	89	Company has received multiple FDA approvals and holds 89 ANDAs. (extranet.who.in
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Approved	Yes	Yes	70	Company has received multiple FDA approvals and holds 70 ANDAs. (extranet.who.in
J B CHEMICALS AND PHARMACEUTICALS LIMITED	Approved	Yes	Yes	45	Company has received multiple FDA approvals and holds 45 ANDAs. (extranet.who.in
KOPRAN LIMITED	Approved	Yes	Yes	30	Company has received multiple FDA approvals and holds 30 ANDAs. (extranet.who.in

TransData Nexus reviewed the regulatory standing of 10 leading Enalapril exporters from India. 4 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 6 are EU GMP compliant. 3 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Enalapril sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as "India's pharmaceutical capital," has been a central hub for bulk drug manufacturing since the establishment of Indian Drugs and Pharmaceuticals Limited (IDPL) in 1961. The city contributes significantly to India's bulk drug production, manufacturing one-third of the nation's bulk drugs and 16% of biotechnology products as of 2010. This robust infrastructure supports the synthesis of active pharmaceutical ingredients (APIs) like Enalapril, ensuring a steady supply for both domestic formulations and international exports.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being pivotal cities in this landscape. Vadodara, for instance, is home to Alembic Pharmaceuticals, established in 1907, which has evolved into a major player in the pharmaceutical industry. These cities host numerous companies specializing in the production of finished dosage forms, including Enalapril tablets, catering to both domestic and international markets.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Enalapril exporters from India

January 2025

M&A

Aurobindo Pharma Ltd — Aurobindo Pharma acquires remaining stake in GLS Pharma

Aurobindo Pharma Ltd completed the acquisition of the remaining 49% stake in GLS Pharma, a Hyderabad-based oncology company, thereby gaining full ownership. - IMPACT: This acquisition is expected to enhance Aurobindo's oncology portfolio, potentially influencing its strategic focus and resource allocation, which may indirectly affect its Enalapril export operations.

Impact: This acquisition is expected to enhance Aurobindo's oncology portfolio, potentially influencing its strategic focus and resource allocation, which may indirectly affect its Enalapril export operations.

November 2024

M&A

Viatris (formerly Mylan Laboratories Limited) — Viatris divests certain businesses for $3.6 billion

Viatris announced the divestiture of select businesses for $3.6 billion as part of its ongoing strategic realignment. - IMPACT: The divestiture may lead to changes in Viatris's operational focus, potentially impacting its Enalapril production and export strategies.

Impact: The divestiture may lead to changes in Viatris's operational focus, potentially impacting its Enalapril production and export strategies.

Common Questions — Enalapril Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which enalapril supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 91 recorded shipments worth $197.1M. IPCA LABORATORIES LIMITED (123 shipments) and J B CHEMICALS AND PHARMACEUTICALS LIMITED (361 shipments) are also established high-volume exporters.

Q How many enalapril manufacturers are there in India?

India has 261 active enalapril exporters with a combined export market of $235.3M across 3,403 shipments to 115 countries. The top 5 suppliers hold 91.5% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for enalapril from India?

Average FOB unit price: $5.32 per unit, ranging from $0.00 to $1024.25. Average shipment value: $69.1K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Enalapril

Enalapril

Who Exports Enalapril from India — 261 Suppliers Behind a $235.3M Market

Top Enalapril Exporters from India — Ranked by Export Value

Top Enalapril Exporters from India

Related Analysis

Need Details?

Enalapril — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Aurobindo Pharma Ltd — Aurobindo Pharma acquires remaining stake in GLS Pharma

Viatris (formerly Mylan Laboratories Limited) — Viatris divests certain businesses for $3.6 billion

Common Questions — Enalapril Suppliers from India

Q Which enalapril supplier from India is the most reliable for bulk orders?

Q How many enalapril manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for enalapril from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Viatris (formerly Mylan Laboratories Limited) — US FDA restricts imports from Viatris's India facility

Analysis Methodology